Has Paul Marr, MD received payments from drug or device companies?

Yes. Drug and device makers reported $600 in general payments to Paul Marr, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Marr, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Marr, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Marr, MD

Sports Medicine · Reading, PANPI 1407854961

Payments from drug & device makers

$600in general payments, 2019–2025

Across 27 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$128
Stryker$69
Organogenesis Inc.$45
Vertex$41
Bioventus LLC$38
Treace Medical Concepts, Inc.$38
plus $240 from 10 others

What the payments were for

Food & beverage$600100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	6	$128
Stryker	1	$69
Organogenesis Inc.	2	$45
Vertex	2	$41
Bioventus LLC	2	$38
Treace Medical Concepts, Inc.	1	$38
Paratek Pharmaceuticals, Inc.	2	$37
Pacira Pharmaceuticals Incorporated	2	$36
Zimmer Biomet	1	$26
Amgen	2	$26
Curonix LLC	1	$25
Orthofix Medical, Inc.	1	$24
Ferring Pharmaceuticals Inc.	1	$21
Sanofi-aventis U.S. LLC	1	$17
ERMI LLC	1	$16
Zyla Life Sciences, Inc.	1	$13

How this compares

$600 in reported general payments places this provider in the 45th percentile of 311 sports medicine providers in Pennsylvania.

See all sports medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$167,561

Medicare patients

353

Services billed

4,772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	39	$578
Meloxicam	30	$140
Prednisone	48	$117
Gabapentin	27	$93
Cyclobenzaprine Hcl	17	$55
Tramadol Hcl	12	$46

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other sports medicine in Reading